Shanghai EGT Synbio Group Announces Self-GRAS Status for EquoPro® S-Equol

Shanghai EGT Synbio Group Co., Ltd. announced that its independently developed and manufactured EquoPro® S-Equol has successfully completed a Self-GRAS assessment in the United States, marking an important milestone in the ingredient’s safety evaluation for dietary supplement applications.

The Self-GRAS conclusion was established through a comprehensive review conducted by an independent U.S. expert team, covering ingredient identity, manufacturing process, quality control, safety data, toxicological evidence, and intended conditions of use.

For global dietary supplement and women’s health brands, this milestone provides a stronger scientific and regulatory foundation for product development, market entry, and premium positioning.

GRAS, short for Generally Recognized as Safe, is an important safety framework in the United States for food ingredients, dietary ingredients, and other substances intended for use in food-related applications.

A Self-GRAS determination means that a company, based on publicly available scientific evidence, safety data, and intended use conditions, organizes an independent panel of qualified experts to evaluate whether an ingredient can be considered generally recognized as safe.

For EquoPro® S-Equol, the Self-GRAS assessment report was completed by a U.S. expert team. The review covered multiple dimensions, including ingredient characterization, production process, product specifications, quality control, toxicological evidence, and safety evaluation.

This process provides a systematic safety basis for EquoPro® as an advanced ingredient for dietary supplement and women’s health formulations.

Q: What is Self-GRAS?
A: Self-GRAS refers to a safety determination made by a company with the support of qualified independent experts, based on scientific evidence, publicly available data, and the intended use of the ingredient.

Q: Is Self-GRAS the same as FDA approval?
A: No. Self-GRAS should not be described as FDA approval or FDA certification. It is a safety conclusion reached through expert evaluation. If submitted to FDA under the GRAS notification process, FDA may issue a response letter, but Self-GRAS itself is not an approval.

Q: Why is Self-GRAS important for brands?
A: It provides a structured safety foundation that helps brands, contract manufacturers, distributors, and regulatory teams evaluate whether an ingredient is suitable for specific product development and market entry strategies.

The value of EquoPro® S-Equol goes beyond the ingredient itself. It is designed to address several long-standing pain points in the women’s health and soy isoflavone markets, especially in relation to activity, conversion efficiency, and scalable supply.

S-Equol is a metabolite that can be naturally produced from soy isoflavones by specific intestinal bacteria in some individuals. However, not all people can efficiently convert soy isoflavones into S-Equol through gut metabolism. This creates a significant gap between traditional soy-based supplementation and targeted active delivery.

EquoPro® provides the specific S-configuration isomer of equol, rather than a mixed racemic form. This is important because S-Equol is the biologically relevant form associated with selective affinity for estrogen receptor beta, or ERβ, which is widely discussed in women’s health, bone health, cardiovascular support, and healthy aging research.

By directly supplying S-Equol, EquoPro® helps brands develop more precise and consistent formulations without relying on uncertain individual gut conversion.

Q: What problem does EquoPro® solve compared with soy isoflavones?
A: Traditional soy isoflavones depend on gut microbiota conversion to generate S-Equol. Since only part of the population can naturally produce S-Equol efficiently, product performance may vary among consumers. EquoPro® provides direct S-Equol delivery.

Q: Why does the S-configuration matter?
A: Equol exists in different stereoisomeric forms. The S-form is considered the biologically relevant form associated with targeted activity. Providing a defined S-Equol ingredient helps avoid dilution of performance caused by racemic mixtures.

Q: What product categories can EquoPro® support?
A: EquoPro® can support women’s health supplements, menopause-support formulas, healthy-aging products, bone health formulations, cardiovascular wellness products, and premium nutraceutical applications, subject to local regulatory requirements.